NPI: 1518993880 · NEENAH, WI 54956 · General Acute Care Hospital · NPI assigned 06/25/2006
Authorized official FLETT, WILLIAM controls 20+ related entities in our dataset. Read more
| Authorized Official | FLETT, WILLIAM (CFO) |
| Parent Organization | THEDACARE, INC. |
| NPI Enumeration Date | 06/25/2006 |
Other providers sharing the same authorized official: FLETT, WILLIAM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 125,865 | $2.65M |
| 2019 | 134,309 | $2.48M |
| 2020 | 132,728 | $2.23M |
| 2021 | 154,035 | $2.35M |
| 2022 | 158,585 | $2.37M |
| 2023 | 175,635 | $2.58M |
| 2024 | 182,549 | $3.57M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,408 | 15,278 | $960K |
| 80048 | Basic metabolic panel (calcium, ionized) | 55,221 | 43,766 | $879K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 18,148 | 15,198 | $808K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,919 | 5,021 | $798K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,860 | 8,000 | $560K |
| 84443 | Thyroid stimulating hormone (TSH) | 37,712 | 34,083 | $516K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,625 | 4,602 | $442K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 17,679 | 16,294 | $440K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,278 | 2,114 | $432K |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | 271 | 190 | $404K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,979 | 7,907 | $393K |
| 87507 | 1,269 | 1,146 | $373K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 9,911 | 7,578 | $343K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 28,230 | 25,065 | $325K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 51,384 | 41,516 | $323K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,912 | 4,347 | $310K |
| G0378 | Hospital observation service, per hour | 8,031 | 3,423 | $308K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1,648 | 1,445 | $307K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9,684 | 8,578 | $303K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9,662 | 8,569 | $277K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,358 | 3,767 | $261K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,017 | 4,353 | $234K |
| 80076 | 31,039 | 25,751 | $233K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,352 | 3,002 | $229K |
| 87631 | 1,797 | 1,607 | $194K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,307 | 3,706 | $193K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,420 | 1,120 | $189K |
| 93320 | 1,682 | 1,468 | $176K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,438 | 1,282 | $175K |
| 80061 | Lipid panel | 14,698 | 13,469 | $173K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,078 | 1,653 | $169K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 7,948 | 7,059 | $166K |
| 80306 | 10,850 | 9,197 | $157K | |
| 87070 | 11,534 | 10,436 | $151K | |
| 82728 | 11,668 | 10,711 | $148K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,865 | 2,320 | $145K |
| 87480 | 8,063 | 7,277 | $138K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,050 | 1,211 | $137K |
| 93325 | 2,225 | 1,943 | $130K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 9,285 | 8,500 | $128K |
| 99215 | Prolong outpt/office vis | 1,960 | 1,407 | $127K |
| 84439 | 10,845 | 9,824 | $124K | |
| 82607 | 9,169 | 8,431 | $122K | |
| 87510 | 8,291 | 7,489 | $121K | |
| 86803 | 9,311 | 8,449 | $119K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,510 | 1,618 | $113K |
| 87660 | 6,520 | 5,884 | $110K | |
| A0436 | Rotary wing air mileage, per statute mile | 246 | 176 | $108K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,247 | 1,110 | $86K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,353 | 1,777 | $85K |
| 85610 | 13,401 | 9,818 | $83K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,378 | 1,232 | $79K |
| 83880 | 3,236 | 2,838 | $79K | |
| 87150 | 2,541 | 2,358 | $74K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 413 | 369 | $73K |
| 84484 | 9,160 | 5,964 | $73K | |
| 84481 | 5,243 | 4,741 | $73K | |
| 86850 | 4,946 | 4,226 | $72K | |
| 86780 | 7,750 | 6,871 | $71K | |
| 84702 | 3,481 | 2,442 | $69K | |
| 83655 | 5,588 | 5,142 | $67K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,795 | 1,609 | $65K |
| 87186 | 9,239 | 8,247 | $64K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,595 | 1,218 | $64K |
| 86480 | 995 | 794 | $63K | |
| 80053 | Comprehensive metabolic panel | 3,143 | 2,693 | $61K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 13,331 | 10,646 | $61K |
| 71046 | Radiologic examination, chest; 2 views | 4,730 | 4,241 | $60K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,316 | 1,109 | $59K |
| 83690 | 10,325 | 8,770 | $58K | |
| 81001 | 16,136 | 13,858 | $56K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 655 | 598 | $56K |
| 76770 | 748 | 636 | $55K | |
| 83970 | 1,715 | 1,513 | $54K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,091 | 969 | $53K |
| 87088 | 8,257 | 7,467 | $52K | |
| 87340 | 6,326 | 5,571 | $50K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,248 | 1,118 | $50K |
| 86140 | 9,245 | 7,886 | $48K | |
| 86618 | 3,611 | 2,401 | $48K | |
| 87081 | 4,507 | 4,086 | $46K | |
| 84403 | 1,975 | 1,780 | $45K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 819 | 728 | $45K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,905 | 1,661 | $42K |
| 83550 | 5,796 | 5,307 | $38K | |
| 85027 | 7,045 | 5,824 | $38K | |
| 82948 | 5,764 | 2,181 | $38K | |
| 81025 | 4,037 | 3,553 | $38K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 118 | 107 | $37K |
| 83540 | 6,726 | 6,163 | $36K | |
| 82565 | 4,458 | 3,703 | $36K | |
| 82746 | 3,111 | 2,820 | $35K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 2,284 | 2,118 | $35K |
| 86762 | 2,809 | 2,498 | $34K | |
| 82274 | 2,409 | 2,222 | $32K | |
| 84146 | 1,746 | 1,556 | $32K | |
| 97803 | 2,866 | 2,544 | $31K | |
| 83735 | 5,952 | 4,594 | $30K | |
| 87522 | Neg quan hep c or qual rna | 678 | 610 | $29K |
| 84703 | 3,774 | 3,307 | $29K | |
| 86787 | 3,943 | 3,439 | $28K | |
| 82570 | 5,551 | 4,762 | $28K | |
| 83516 | 3,071 | 1,743 | $27K | |
| 82077 | 3,066 | 2,504 | $27K | |
| 83001 | 1,476 | 1,364 | $26K | |
| 82784 | 1,899 | 1,562 | $26K | |
| 82947 | 4,794 | 3,378 | $25K | |
| 86704 | 2,658 | 2,278 | $25K | |
| 80164 | 1,214 | 1,084 | $25K | |
| 87650 | 459 | 434 | $24K | |
| 82150 | 2,888 | 2,504 | $24K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 390 | 351 | $23K |
| 86703 | 1,337 | 1,266 | $22K | |
| 86900 | 4,924 | 4,174 | $21K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 478 | 438 | $21K |
| 86200 | 1,299 | 1,158 | $21K | |
| 73610 | 1,568 | 1,324 | $20K | |
| 86706 | 2,257 | 1,956 | $20K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,800 | 2,506 | $20K |
| 86235 | 1,153 | 313 | $19K | |
| 82670 | 722 | 645 | $19K | |
| 85380 | 2,357 | 2,116 | $18K | |
| 86364 | 1,531 | 1,055 | $18K | |
| 93971 | 525 | 475 | $18K | |
| 82043 | 2,715 | 2,510 | $18K | |
| 84402 | 778 | 683 | $18K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 53 | 38 | $17K |
| 96367 | 345 | 236 | $17K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 738 | 175 | $16K |
| 84425 | 1,035 | 920 | $16K | |
| 87040 | 2,395 | 1,297 | $16K | |
| 80143 | 1,668 | 1,406 | $16K | |
| 84460 | 3,436 | 2,819 | $15K | |
| 80179 | 1,614 | 1,369 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 197 | 167 | $14K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 667 | 518 | $14K |
| 73110 | 815 | 641 | $14K | |
| 82950 | 1,178 | 1,084 | $14K | |
| 84450 | 2,898 | 2,397 | $14K | |
| 86481 | 255 | 235 | $14K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 70 | 67 | $14K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 416 | 367 | $14K |
| 86038 | 1,290 | 1,157 | $14K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 158 | 143 | $13K |
| 83605 | 1,943 | 1,555 | $13K | |
| 87529 | 418 | 211 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,860 | 8,859 | $13K |
| 87653 | 301 | 286 | $13K | |
| 83520 | 944 | 770 | $13K | |
| 85652 | 5,618 | 4,877 | $12K | |
| 76830 | Ultrasound, transvaginal | 303 | 277 | $12K |
| 85730 | 3,066 | 2,592 | $12K | |
| 82550 | 1,630 | 1,337 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,791 | 3,604 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,697 | 3,337 | $11K |
| 86901 | 4,931 | 4,172 | $11K | |
| 86039 | 1,297 | 1,088 | $11K | |
| 87493 | 315 | 286 | $11K | |
| 81003 | 3,366 | 2,946 | $10K | |
| 86431 | 1,827 | 1,639 | $10K | |
| 12001 | 114 | 101 | $9K | |
| 74018 | 966 | 832 | $9K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 176 | 156 | $9K |
| 97802 | 467 | 387 | $9K | |
| 80178 | 1,047 | 921 | $9K | |
| 84156 | 2,870 | 2,260 | $9K | |
| 84270 | 484 | 422 | $9K | |
| 84100 | 2,609 | 2,048 | $9K | |
| 87807 | 511 | 477 | $8K | |
| 70496 | 90 | 80 | $8K | |
| 84550 | 2,066 | 1,757 | $8K | |
| 86376 | 664 | 599 | $8K | |
| 70498 | 94 | 81 | $8K | |
| 87147 | 1,612 | 1,471 | $8K | |
| 82962 | 1,488 | 693 | $7K | |
| 82017 | 199 | 179 | $7K | |
| 71045 | Radiologic examination, chest; single view | 7,583 | 6,502 | $7K |
| 83002 | 468 | 426 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,470 | 8,314 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 312 | 280 | $7K |
| 84144 | 206 | 152 | $7K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 135 | 90 | $7K |
| 82330 | 590 | 513 | $7K | |
| 82533 | 302 | 235 | $6K | |
| 86800 | 350 | 320 | $6K | |
| 80055 | 508 | 281 | $6K | |
| 86592 | 1,047 | 972 | $6K | |
| 86696 | 285 | 269 | $6K | |
| 86003 | 451 | 125 | $6K | |
| 87077 | 884 | 806 | $6K | |
| 93970 | 133 | 125 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 371 | 344 | $5K |
| 86666 | 1,089 | 571 | $5K | |
| 82805 | 124 | 93 | $5K | |
| 84132 | 1,202 | 1,009 | $5K | |
| 82731 | 70 | 63 | $5K | |
| 84112 | 74 | 65 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 13 | 13 | $5K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 180 | 159 | $5K |
| 87486 | 118 | 107 | $5K | |
| 85014 | 1,814 | 1,435 | $5K | |
| 86753 | 603 | 542 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 694 | 502 | $4K |
| 86695 | 285 | 269 | $4K | |
| 83498 | 281 | 251 | $4K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59 | 54 | $4K |
| 73630 | 705 | 638 | $4K | |
| 83789 | 281 | 248 | $4K | |
| 82105 | 221 | 205 | $4K | |
| 80175 | 245 | 214 | $4K | |
| 87581 | 116 | 105 | $4K | |
| 73590 | 265 | 206 | $4K | |
| 84165 | 335 | 306 | $3K | |
| 83521 | 159 | 135 | $3K | |
| 85379 | 376 | 331 | $3K | |
| 97804 | 478 | 428 | $3K | |
| 82040 | 217 | 189 | $3K | |
| 76642 | 101 | 88 | $2K | |
| 43235 | 12 | 12 | $2K | |
| 87469 | 80 | 76 | $2K | |
| 84145 | 95 | 88 | $2K | |
| 87468 | 79 | 75 | $2K | |
| 87484 | 79 | 75 | $2K | |
| 82977 | 298 | 236 | $2K | |
| 96376 | 4,309 | 2,935 | $2K | |
| 82803 | 58 | 43 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 22,479 | 17,116 | $2K |
| 85018 | 1,182 | 899 | $2K | |
| 97597 | 45 | 27 | $2K | |
| 86160 | 118 | 95 | $2K | |
| 84630 | 239 | 212 | $2K | |
| 87075 | 314 | 232 | $2K | |
| 80177 | 129 | 117 | $2K | |
| 86694 | 117 | 97 | $2K | |
| 73030 | 430 | 378 | $2K | |
| 76000 | 25 | 24 | $2K | |
| 82261 | 199 | 179 | $2K | |
| 72100 | 234 | 215 | $2K | |
| 86708 | 174 | 146 | $2K | |
| 88307 | 193 | 169 | $2K | |
| 82760 | 199 | 179 | $1K | |
| 81015 | 194 | 171 | $1K | |
| 84510 | 199 | 179 | $1K | |
| 83615 | 284 | 232 | $1K | |
| 87210 | 248 | 228 | $1K | |
| 76536 | 46 | 38 | $1K | |
| 83020 | 298 | 270 | $1K | |
| 36430 | 21 | 14 | $1K | |
| 36592 | 1,365 | 857 | $1K | |
| 84295 | 390 | 321 | $1K | |
| 80299 | 15 | 13 | $1K | |
| 73130 | 275 | 251 | $1K | |
| 97166 | 80 | 68 | $1K | |
| 87205 | 422 | 332 | $1K | |
| 90715 | 177 | 162 | $1K | |
| 73502 | 114 | 105 | $1K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 14 | 14 | $1K |
| 80197 | 102 | 71 | $982.42 | |
| 84153 | 73 | 64 | $959.07 | |
| 82378 | 41 | 38 | $958.94 | |
| J2704 | Injection, propofol, 10 mg | 9,112 | 7,290 | $946.83 |
| 71250 | 26 | 25 | $934.39 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13 | 12 | $892.15 |
| 97162 | 65 | 56 | $883.38 | |
| 93017 | 12 | 12 | $866.81 | |
| 86225 | 89 | 71 | $823.52 | |
| 83525 | 68 | 65 | $782.28 | |
| 83993 | 43 | 42 | $774.00 | |
| 86617 | 88 | 41 | $744.89 | |
| 84030 | 199 | 179 | $740.03 | |
| 86705 | 114 | 87 | $720.71 | |
| 80050 | General health panel | 54 | 26 | $710.70 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 56 | 26 | $688.32 |
| J3490 | Unclassified drugs | 2,846 | 2,256 | $666.36 |
| 0042T | 19 | 12 | $646.83 | |
| 82951 | 48 | 46 | $611.50 | |
| 84480 | 51 | 43 | $602.83 | |
| 93226 | 30 | 30 | $563.83 | |
| 87209 | 31 | 26 | $524.15 | |
| 86709 | 58 | 53 | $510.61 | |
| 0097U | 242 | 219 | $501.15 | |
| 72040 | 71 | 63 | $480.74 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,485 | 3,844 | $476.12 |
| J1170 | Injection, hydromorphone, up to 4 mg | 5,760 | 3,819 | $475.48 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 26 | 12 | $468.23 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1,284 | 1,132 | $443.85 |
| 73090 | 60 | 38 | $431.08 | |
| 93225 | 16 | 12 | $426.16 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,484 | 7,344 | $403.14 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 12 | 12 | $385.74 |
| 82010 | 48 | 38 | $368.01 | |
| 73564 | 553 | 503 | $359.05 | |
| 87563 | 17 | 14 | $338.52 | |
| 86147 | 23 | 17 | $318.63 | |
| 88342 | 118 | 107 | $277.93 | |
| 87177 | 31 | 26 | $259.55 | |
| J7050 | Infusion, normal saline solution, 250 cc | 10,366 | 5,502 | $248.82 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,170 | 8,030 | $232.17 |
| 86334 | 18 | 16 | $226.09 | |
| 85045 | 58 | 53 | $212.25 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,657 | 663 | $211.40 |
| 82247 | 42 | 31 | $208.87 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,237 | 1,429 | $205.44 |
| J3411 | Injection, thiamine hcl, 100 mg | 284 | 104 | $194.80 |
| 82952 | 47 | 46 | $182.15 | |
| 72170 | 19 | 17 | $180.70 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,522 | 1,215 | $179.70 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,756 | 6,048 | $179.52 |
| 82140 | 17 | 15 | $164.96 | |
| 87338 | 12 | 12 | $164.36 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,844 | 1,386 | $142.66 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 269 | 240 | $138.38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,103 | 5,695 | $128.29 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 351 | 302 | $124.68 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 15,004 | 10,947 | $116.13 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,324 | 2,340 | $113.80 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 1,050 | 924 | $112.22 |
| 82435 | 30 | 29 | $105.52 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,786 | 2,705 | $98.25 |
| 74019 | 74 | 70 | $97.84 | |
| 73552 | 15 | 14 | $96.48 | |
| 84520 | 29 | 27 | $92.85 | |
| C1769 | Guide wire | 728 | 624 | $74.80 |
| 88304 | 138 | 129 | $72.03 | |
| 36591 | 21 | 13 | $70.23 | |
| 99152 | 127 | 116 | $58.57 | |
| 73000 | 16 | 12 | $55.52 | |
| 82465 | 15 | 12 | $54.02 | |
| 85049 | 16 | 15 | $43.45 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 201 | 158 | $40.04 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,008 | 802 | $38.23 |
| 97535 | Self-care/home management training, each 15 minutes | 46 | 26 | $36.99 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 707 | 350 | $32.06 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4,407 | 3,834 | $30.16 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 304 | 216 | $22.87 |
| 0351U | 12 | 12 | $18.56 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,532 | 1,235 | $16.17 |
| J2060 | Injection, lorazepam, 2 mg | 1,833 | 1,372 | $15.83 |
| 97163 | 15 | 12 | $14.75 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,428 | 1,203 | $11.86 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 197 | 172 | $10.21 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 351 | 250 | $8.63 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 44 | 37 | $6.06 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 464 | 246 | $5.90 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 692 | 583 | $5.90 |
| A9270 | Non-covered item or service | 1,802 | 1,034 | $2.33 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 30 | 18 | $0.90 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 110 | 74 | $0.79 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 241 | 156 | $0.42 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 8,461 | 6,618 | $0.23 |
| 99153 | Mod sedat endo service >5yrs | 15 | 13 | $0.09 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 37 | 37 | $0.04 |
| J7030 | Infusion, normal saline solution , 1000 cc | 134 | 106 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 712 | 615 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 285 | 193 | $0.00 |
| 73140 | 13 | 12 | $0.00 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 2,668 | 2,162 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 71 | 64 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 47 | 45 | $0.00 |
| C1758 | Catheter, ureteral | 81 | 78 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 49 | 45 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 149 | 89 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 67 | 55 | $0.00 |
| 0100U | 27 | 25 | $0.00 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 21 | 18 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 60 | 15 | $0.00 |
| 29125 | 15 | 13 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 14 | 12 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 13 | 12 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 19 | 14 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 367 | 320 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 553 | 284 | $0.00 |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | 100 | 95 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 29 | 24 | $0.00 |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | 14 | 13 | $0.00 |